Commentary|Podcasts|January 11, 2024
Dr. Schwen on focal therapies for prostate cancer
Author(s)Cleveland Clinic
Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.
Advertisement
On an episode of Cleveland Clinic’s Cancer Advances podcast, host Dale Shepard, MD, PhD, talked with Zeyad Schwen, MD, about the use of focal therapy to treat patients with localized prostate cancer.
Schwen, who is a urologic oncologist at Cleveland Clinic, covers these topics:
- The difference between traditional treatments and focal therapies
- Factors that make a patient a good candidate for focal therapy
- Focal procedures, including Nanoknife, high-intensity focused ultrasound and cryotherapy
- Risk of recurrence and salvage therapies
- Clinical trials devoted to focal therapies
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Novel tool may help predict early PSA response to ARPIs in mHSPC
2
Dosing begins in trial of alpha radioligand therapy for mCRPC
3
Fed Ghali, MD, highlights trial of consolidative local therapy following EV/P
4
RCMIGI trial supports feasibility of reduced margins in image-guided prostate radiotherapy
5